These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32294659)

  • 1. Neuronal Activity and Synaptic Plasticity in a Reimplanted STN-DBS Patient with Parkinson's Disease: Recordings from Two Surgeries.
    Milosevic L; De Vloo P; Gramer R; Kalia SK; Fasano A; Popovic MR; Hutchison WD
    Stereotact Funct Neurosurg; 2020; 98(3):206-212. PubMed ID: 32294659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal inhibition and synaptic plasticity of basal ganglia neurons in Parkinson's disease.
    Milosevic L; Kalia SK; Hodaie M; Lozano AM; Fasano A; Popovic MR; Hutchison WD
    Brain; 2018 Jan; 141(1):177-190. PubMed ID: 29236966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-frequency stimulation of the subthalamic nucleus restores neural and behavioral functions during reaction time task in a rat model of Parkinson's disease.
    Li XH; Wang JY; Gao G; Chang JY; Woodward DJ; Luo F
    J Neurosci Res; 2010 May; 88(7):1510-21. PubMed ID: 20025062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial extent of β oscillatory activity in and between the subthalamic nucleus and substantia nigra pars reticulata of Parkinson's disease patients.
    Alavi M; Dostrovsky JO; Hodaie M; Lozano AM; Hutchison WD
    Exp Neurol; 2013 Jul; 245():60-71. PubMed ID: 23063495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subthalamic stimulation and neuronal activity in the substantia nigra in Parkinson's disease.
    Maltête D; Jodoin N; Karachi C; Houeto JL; Navarro S; Cornu P; Agid Y; Welter ML
    J Neurophysiol; 2007 Jun; 97(6):4017-22. PubMed ID: 17460099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of specific components of sleep disturbances by simultaneous subthalamic and nigral stimulation in Parkinson's disease.
    Hidding U; Gulberti A; Pflug C; Choe C; Horn A; Prilop L; Braaß H; Fründt O; Buhmann C; Weiss D; Westphal M; Engel AK; Gerloff C; Köppen JA; Hamel W; Moll CKE; Pötter-Nerger M
    Parkinsonism Relat Disord; 2019 May; 62():141-147. PubMed ID: 30616868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent synaptic inhibition of the subthalamic nucleus by high frequency stimulation.
    Steiner LA; Kühn AA; Geiger JR; Alle H; Popovic MR; Kalia SK; Hodaie M; Lozano AM; Hutchison WD; Milosevic L
    Brain Stimul; 2022; 15(5):1223-1232. PubMed ID: 36058524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microstimulation-induced inhibition as a tool to aid targeting the ventral border of the subthalamic nucleus.
    Lafreniere-Roula M; Hutchison WD; Lozano AM; Hodaie M; Dostrovsky JO
    J Neurosurg; 2009 Oct; 111(4):724-8. PubMed ID: 19408978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease.
    Galati S; Mazzone P; Fedele E; Pisani A; Peppe A; Pierantozzi M; Brusa L; Tropepi D; Moschella V; Raiteri M; Stanzione P; Bernardi G; Stefani A
    Eur J Neurosci; 2006 Jun; 23(11):2923-8. PubMed ID: 16819981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic, synaptic and behavioral impact of 5-week chronic deep brain stimulation in hemiparkinsonian rats.
    Chassain C; Melon C; Salin P; Vitale F; Couraud S; Durif F; Kerkerian-Le Goff L; Gubellini P
    J Neurochem; 2016 Mar; 136(5):1004-16. PubMed ID: 26576509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous low-frequency deep brain stimulation of the substantia nigra pars reticulata and high-frequency stimulation of the subthalamic nucleus to treat levodopa unresponsive freezing of gait in Parkinson's disease: A pilot study.
    Valldeoriola F; Muñoz E; Rumià J; Roldán P; Cámara A; Compta Y; Martí MJ; Tolosa E
    Parkinsonism Relat Disord; 2019 Mar; 60():153-157. PubMed ID: 30241951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential modulation of subthalamic projection neurons by short-term and long-term electrical stimulation in physiological and parkinsonian conditions.
    Xiao C; Ji YW; Luan YW; Jia T; Yin C; Zhou CY
    Acta Pharmacol Sin; 2022 Aug; 43(8):1928-1939. PubMed ID: 34880404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular spike microrecordings from the subthalamic area in Parkinson's disease.
    Mrakic-Sposta S; Marceglia S; Egidi M; Carrabba G; Rampini P; Locatelli M; Foffani G; Accolla E; Cogiamanian F; Tamma F; Barbieri S; Priori A
    J Clin Neurosci; 2008 May; 15(5):559-67. PubMed ID: 18378458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stop! border ahead: Automatic detection of subthalamic exit during deep brain stimulation surgery.
    Valsky D; Marmor-Levin O; Deffains M; Eitan R; Blackwell KT; Bergman H; Israel Z
    Mov Disord; 2017 Jan; 32(1):70-79. PubMed ID: 27709666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency-dependent, transient effects of subthalamic nucleus deep brain stimulation on methamphetamine-induced circling and neuronal activity in the hemiparkinsonian rat.
    So RQ; McConnell GC; Grill WM
    Behav Brain Res; 2017 Mar; 320():119-127. PubMed ID: 27939691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subthalamic deep brain stimulation alters neuronal firing in canonical pain nuclei in a 6-hydroxydopamine lesioned rat model of Parkinson's disease.
    Gee LE; Walling I; Ramirez-Zamora A; Shin DS; Pilitsis JG
    Exp Neurol; 2016 Sep; 283(Pt A):298-307. PubMed ID: 27373204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eye movement-related responses of neurons in human subthalamic nucleus.
    Fawcett AP; Dostrovsky JO; Lozano AM; Hutchison WD
    Exp Brain Res; 2005 Apr; 162(3):357-65. PubMed ID: 15599721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of action underlying the efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease: central role of disease severity.
    Stefani A; Cerroni R; Mazzone P; Liguori C; Di Giovanni G; Pierantozzi M; Galati S
    Eur J Neurosci; 2019 Mar; 49(6):805-816. PubMed ID: 30044030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intraoperative subthalamic nucleus DBS on human single-unit activity in the ipsilateral and contralateral subthalamic nucleus.
    Toleikis JR; Metman LV; Pilitsis JG; Barborica A; Toleikis SC; Bakay RA
    J Neurosurg; 2012 May; 116(5):1134-43. PubMed ID: 22339160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
    Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
    Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.